Moreover, another study showed that Gal-3 infusion caused myocardial fibrosis, which was neutralized by an anti-fibrotic agent, suggesting that Gal-3 may be involved in the development and resolution of fibrosis [81]. This evidence concerns the gene LGALS3 and Myocardial fibrosis.